We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




How Foods Fight Cancer

By Biotechdaily staff writers
Posted on 25 Jul 2005
"Compounds like sulforaphane in broccoli and resveratrol in wine have been shown to prevent cancer. More...
They do that by signaling our bodies to ramp up the production of proteins capable of preventing damage to our DNA. We now have a good idea how that signal works,” said Dr. Andrew Mesecar, associate professor of pharmaceutical biotechnology at the University of Illinois at Chicago (UIC) College of Pharmacy (USA), following a recent study.

Two major proteins, Keap1 and Nrf2, are involved in prompting the fight against cancer when disease-preventing foods are ingested, according to the UIC researchers. Keap1, the sensor protein, detects the presence of dietary substances such as sulforaphane when they bind with its cysteine residues, one of the amino acids that make up proteins. Keap1 attaches to Nrf2, the messenger that activates the genes for the protective proteins, avoiding DNA damage.

"Earlier studies in mice suggested that natural cancer-preventing compounds worked by severing the tie between Keap1 and Nrf2, freeing Nrf2 to take action,” Dr. Mesecar remarked. "But the signaling doesn't happen this way in humans.”

The researchers discovered that in humans the connection between the two proteins is not disrupted. What is significant, the investigators reported, is the alteration of cysteines in Keap1. They discovered that one specific cysteine was among the most likely to be modified in the interaction with cancer-preventing compounds.

This finding corresponded with results from other researchers. As a result, the scientists are proposing that the alteration of only this one amino acid in Keap1 is the critical step that triggers increases of the messenger Nrf2, and as a result, increased production of the protective proteins.

Keap1 is a potential new target for drugs to combat many different types of cancer, according to Dr. Mesecar. "One way of preventing cancer may be to eat certain foods rich in cancer-preventing compounds. An alternative is identifying how these compounds work and replicating their modes of action with drugs,” noted Dr. Mesecar.

The study was published in the June 12, 2005, online edition of the Proceedings of the [U.S.] National Academy of Sciences.




Related Links:
University of Illinois at Chicago

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.